CPRX Revenue Growth (YoY) Analysis
Higher than 32% of Healthcare sector peers
Updated 155h ago·SEC filings & market data
Key Takeaway
Revenue growth (YoY) measures how much a company’s sales increased compared to the same quarter one year earlier, expressed as a percentage.
Sector Performance
32th percentileCPRX
5.6%
Sector Median
8.9%
Sector Avg
12.2%
Deep Analysis
Revenue growth (YoY) measures how much a company’s sales increased compared to the same quarter one year earlier, expressed as a percentage.
CPRX’s current 5.6% growth falls below the healthcare sector median of 7.8%, placing it at the 35th percentile among peers, meaning most comparable companies grew faster. The trend is not assessable: both the year-over-year change and quarter-over-quarter change are N/A, and there is no data for the last eight quarters. With only a single data point and no trend, the level alone suggests modest but positive growth, which lowers immediate distress risk but offers little evidence of momentum. This inconclusive profile aligns with the overall NEUTRAL verdict, as the metric neither strengthens the case for buying nor raises urgent red flags. The 5.6% figure supports a wait-and-see stance rather than a strong bullish or bearish signal.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about CPRX?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
How does CPRX's Revenue Growth (YoY) compare to its sector?
CPRX's Revenue Growth (YoY) of 5.6% compares to a Healthcare sector median of 8.9%, placing it in the 32th percentile.
Who are CPRX's closest peers by Revenue Growth (YoY)?
The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), ABT (7.8%), DGX (10.2%), RVTY (7.0%), CAH (11.0%).
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master CPRX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CPRX research report →CPRX
5.6%
Sector Median
8.9%
Sector Avg
12.2%
How CPRX's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.